Participants 0 99 4
The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.
Participants 101 470 5
This double-blind and placebo-controlled clinical trial in autistic children had three objectives: (a) to replicate earlier findings that haloperidol administration is associated with a significant reduction of behavioral symptoms; (b) to further assess its safety when given on a short-term basis; and (c) to assess whether it has an effect on discrimination learning.
Participants 471 559 6
Forty-five children, 2.02 to 7.58 years old (M = 4.49), completed this crossover design,
